Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-06

FDA Approved: BIMATOPROST — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved the Original Application for BIMATOPROST (bimatoprost) by Aurobindo Pharma Limited under ANDA205537.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

ORIG AP for BIMATOPROST (BIMATOPROST)